MSB 1.34% $1.51 mesoblast limited

MSB Trading 2021 - paradigm shift, page-159

  1. 3,911 Posts.
    lightbulb Created with Sketch. 367
    it depends how you see it. What they said was the Norvatis conditions are confidential, therefore wasn't announced to market. Now, this article which was posted on HC, how credible is it?

    Also, the article did state it came from Norvatis and not MSB.

    Also, Julie Lee said in the Switzer call that the back pain trial will be announced in Feb.

    Communication is very very poor from MSB.

    Next web call, I'll be commenting on it!
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.